Role of the long non‑coding RNA‑Annexin A2 pseudogene 3/Annexin A2 signaling pathway in biliary atresia‑associated hepatic injury

Nuerzhati,Yeletai; Dong,Rui; Song,Zai; Zheng,Shan

doi:10.3892/ijmm.2018.4023

Role of the long non‑coding RNA‑Annexin A2 pseudogene 3/Annexin A2 signaling pathway in biliary atresia‑associated hepatic injury

Authors:
- Yeletai Nuerzhati
- Rui Dong
- Zai Song
- Shan Zheng
View Affiliations

Affiliations: Department of Pediatric Hepatobiliary Surgery, Children's Hospital of Fudan University, Shanghai 201102, P.R. China
Published online on: December 11, 2018 https://doi.org/10.3892/ijmm.2018.4023
Pages: 739-748
Copyright: © Nuerzhati et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Biliary atresia (BA) is the most common cause of chronic cholestasis in children. The long non‑coding RNA (lncRNA) Annexin A2 pseudogene 3 (ANXA2P3) and Annexin A2 (ANXA2) have been suggested to serve pivotal roles in BA; however, the clinical significance and biological roles of ANXA2P3 and ANXA2 in BA remain to be elucidated. The present study aimed to elucidate the function of ANAX2P3 and ANXA2 in BA‑induced liver injury using a human liver cell line and liver tissues from patients with BA. Reverse transcription‑quantitative polymerase chain reaction, western blotting and immunohistochemistry were conducted to determine the expression levels of ANXA2 and ANXA2P3 in liver tissues from patients with BA. Classification of fibrosis was analyzed by Masson staining. The functional roles of ANXA2 and ANXA2P3 in liver cells were determined by Cell Counting kit‑8 assay, and flow cytometric and cell cycle analyses. Activation of the ANXA2/ANXA2P3 signaling pathway in liver cells was evaluated by western blot analysis. According to the present results, the expression levels of ANXA2 and ANXA2P3 were significantly increased in liver tissues from patients with BA. In addition, knocking down the expression of ANXA2P3 and ANXA2 may result in reduced liver cell proliferation, cell cycle arrest in G1 phase and increased apoptosis of liver cells in vitro. Furthermore, in cells in which ANXA2 and ANXA2P3 were overexpressed, cell apoptosis was reduced and cell cycle arrest in G2 phase. Taken together, these results indicated that ANXA2P3 and ANXA2 may have protective effects against liver injury progression and may be considered biomarkers in patients with BA.

View Figures

View References

1	Asai A, Miethke A and Bezerra JA: Pathogenesis of biliary atresia: Defining biology to understand clinical phenotypes. Nat Rev Gastroenterol Hepatol. 12:342–352. 2015. View Article : Google Scholar : PubMed/NCBI
2	Dehghani SM, Efazati N, Shahramian I, Haghighat M and Imanieh MH: Evaluation of cholestasis in Iranian infants less than three months of age. Gastroenterol Hepatol Bed Bench. 8:42–48. 2015.PubMed/NCBI
3	Hoerning A, Raub S, Dechêne A, Brosch MN, Kathemann S, Hoyer PF and Gerner P: Diversity of disorders causing neonatal cholestasis-the experience of a tertiary pediatric center in Germany. Front Pediatr. 2:652014. View Article : Google Scholar
4	Lishuang M, Zhen C, Guoliang Q, Zhen Z, Chen W, Long L and Shuli L: Laparoscopic portoenterostomy versus open portoenterostomy for the treatment of biliary atresia: A systematic review and meta-analysis of comparative studies. Pediatr Surg Int. 31:261–269. 2015. View Article : Google Scholar : PubMed/NCBI
5	Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, et al: The sequence of the human genome. Science. 291:1304–1351. 2001. View Article : Google Scholar : PubMed/NCBI
6	Yang Y, Wen L and Zhu H: Unveiling the hidden function of long non-coding RNA by identifying its major partner-protein. Cell Biosci. 5:592015. View Article : Google Scholar : PubMed/NCBI
7	Wilczynska A and Bushell M: The complexity of miRNA-mediated repression. Cell Death Differ. 22:22–33. 2015. View Article : Google Scholar
8	Fang XY, Pan HF, Leng RX and Ye DQ: Long noncoding RNAs: Novel insights into gastric cancer. Cancer Lett. 356:357–366. 2015. View Article : Google Scholar
9	Chen Z, Luo Y, Yang W, Ding L, Wang J, Tu J, Geng B, Cui Q and Yang J: Comparison analysis of dysregulated LncRNA profile in mouse plasma and liver after hepatic ischemia/reperfusion injury. PLoS One. 10:e01334622015. View Article : Google Scholar : PubMed/NCBI
10	He Y, Wu YT, Huang C, Meng XM, Ma TT, Wu BM, Xu FY, Zhang L, Lv XW and Li J: Inhibitory effects of long noncoding RNA MEG3 on hepatic stellate cells activation and liver fibro-genesis. Biochim Biophys Acta. 1842:2204–2215. 2014. View Article : Google Scholar : PubMed/NCBI
11	Qiao J, Yao H, Xia Y, Chu P, Li M, Wu Y, Li W, Ding L, Qi K, Li D, et al: Long non-coding RNAs expression profiles in hepatocytes of mice after hematopoietic stem cell transplantation. IUBMB Life. 68:232–241. 2016. View Article : Google Scholar : PubMed/NCBI
12	Su S, Liu J, He K, Zhang M, Feng C, Peng F, Li B and Xia X: Overexpression of the long noncoding RNA TUG1 protects against cold-induced injury of mouse livers by inhibiting apoptosis and inflammation. FEBS J. 283:1261–1274. 2016. View Article : Google Scholar : PubMed/NCBI
13	Liu H, Song G, Zhou L, Hu X, Liu M, Nie J, Lu S, Wu X, Cao Y, Tao L, et al: Compared analysis of LncRNA expression profiling in pdk1 gene knockout mice at two time points. Cell Physiol Biochem. 32:1497–1508. 2013. View Article : Google Scholar : PubMed/NCBI
14	Xu D, Yang F, Yuan JH, Zhang L, Bi HS, Zhou CC, Liu F, Wang F and Sun SH: Long noncoding RNAs associated with liver regeneration 1 accelerates hepatocyte proliferation during liver regeneration by activating Wnt/beta-catenin signaling. Hepatology. 58:739–751. 2013. View Article : Google Scholar : PubMed/NCBI
15	Groen JN, Capraro D and Morris KV: The emerging role of pseudogene expressed non-coding RNAs in cellular functions. Int J Biochem Cell Biol. 54:350–355. 2014. View Article : Google Scholar : PubMed/NCBI
16	Piehler AP, Hellum M, Wenzel JJ, Kaminski E, Haug KB, Kierulf P and Kaminski WE: The human ABC transporter pseudogene family: Evidence for transcription and gene-pseudogene interference. BMC Genomics. 9:1652008. View Article : Google Scholar : PubMed/NCBI
17	Lin H, Shabbir A, Molnar M and Lee T: Stem cell regulatory function mediated by expression of a novel mouse Oct4 pseudogene. Biochem Biophys Res Commun. 355:111–116. 2007. View Article : Google Scholar : PubMed/NCBI
18	Karreth FA, Reschke M, Ruocco A, Ng C, Chapuy B, Léopold V, Sjoberg M, Keane TM, Verma A, Ala U, et al: The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo. Cell. 161:319–332. 2015. View Article : Google Scholar : PubMed/NCBI
19	Li S, Zou H, Shao YY, Mei Y, Cheng Y, Hu DL, Tan ZR and Zhou HH: Pseudogenes of annexin A2, novel prognosis biomarkers for diffuse gliomas. Oncotarget. 8:106962–106975. 2017.
20	Pan BL, Tong ZW, Wu L, Pan L, Li JE, Huang YG, Li SD, Du SX and Li XD: Effects of MicroRNA-206 on osteosarcoma cell proliferation, apoptosis, migration and invasion by targeting ANXA2 through the AKT signaling pathway. Cell Physiol Biochem. 45:1410–1422. 2018. View Article : Google Scholar : PubMed/NCBI
21	Pérez-Sánchez G, Jiménez A, Quezada-Ramírez MA, Estudillo E, Ayala-Sarmiento AE, Mendoza-Hernández G, Hernández-Soto J, Hernández-Hernández FC, Cázares-Raga FE and Segovia J: Annexin A1, Annexin A2, and Dyrk 1B are upregulated during GAS1-induced cell cycle arrest. J Cell Physiol. 233:4166–4182. 2018. View Article : Google Scholar
22	Chen J, Cui Z, Yang S, Wu C, Li W, Bao G, Xu G, Sun Y, Wang L and Zhang J: The upregulation of annexin A2 after spinal cord injury in rats may have implication for astrocyte proliferation. Neuropeptides. 61:67–76. 2017. View Article : Google Scholar
23	Stewart AG, Xia YC, Harris T, Royce S, Hamilton JA and Schuliga M: Plasminogen-stimulated airway smooth muscle cell proliferation is mediated by urokinase and annexin A2, involving plasmin-activated cell signalling. Br J Pharmacol. 170:1421–1435. 2013. View Article : Google Scholar : PubMed/NCBI
24	Dong Z, Yao M, Zhang H, Wang L, Huang H, Yan M, Wu W and Yao D: Inhibition of Annexin A2 gene transcription is a promising molecular target for hepatoma cell proliferation and metastasis. Oncol Lett. 7:28–34. 2014. View Article : Google Scholar
25	Jiang SL, Pan DY, Gu C, Qin HF and Zhao SH: Annexin A2 silencing enhances apoptosis of human umbilical vein endothelial cells in vitro. Asian Pac J Trop Med. 8:952–957. 2015. View Article : Google Scholar : PubMed/NCBI
26	Kolgelier S, Demir NA, Inkaya AC, Sumer S, Ozcimen S, Demir LS, Pehlivan FS, Arslan M and Arpaci A: Serum levels of Annexin A2 as a candidate biomarker for hepatic fibrosis in patients with chronic hepatitis B. Hepat Mon. 15:e306552015. View Article : Google Scholar : PubMed/NCBI
27	Zhang L, Peng X, Zhang Z, Feng Y, Jia X, Shi Y, Yang H, Zhang Z, Zhang X, Liu L, et al: Subcellular proteome analysis unraveled annexin A2 related to immune liver fibrosis. J Cell Biochem. 110:219–228. 2010.PubMed/NCBI
28	Yang M, Wang C, Li S, Xv X, She S, Ran X, Li S, Hu H, Hu P, Zhang D, et al: Annexin A2 promotes liver fibrosis by mediating von Willebrand factor secretion. Dig Liver Dis. 49:780–788. 2017. View Article : Google Scholar : PubMed/NCBI
29	Dadhania VP, Muskhelishvili L, Latendresse JR and Mehendale HM: Hepatic overexpression of Annexin A1 and A2 in thioacetamide-primed mice protects them against acetaminophen-induced liver failure and death. Int J Toxicol. 35:654–665. 2016. View Article : Google Scholar : PubMed/NCBI
30	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
31	Weerasooriya VS, White FV and Shepherd RW: Hepatic fibrosis and survival in biliary atresia. J Pediatr. 144:123–125. 2004. View Article : Google Scholar : PubMed/NCBI
32	Blythe AJ, Fox AH and Bond CS: The ins and outs of lncRNA structure: How, why and what comes next. Biochim Biophys Acta. 1859:46–58. 2016. View Article : Google Scholar
33	Liz J and Esteller M: lncRNAs and microRNAs with a role in cancer development. Biochim Biophys Acta. 1859:169–176. 2016. View Article : Google Scholar
34	Zhang H, Chen Z, Wang X, Huang Z, He Z and Chen Y: Long non-coding RNA: A new player in cancer. J Hematol Oncol. 6:372013. View Article : Google Scholar : PubMed/NCBI
35	Pink RC and Carter DR: Pseudogenes as regulators of biological function. Essays Biochem. 54:103–112. 2013. View Article : Google Scholar : PubMed/NCBI
36	Zhou X, Deng S, Liu H, Liu Y, Yang Z, Xing T, Jing B and Zhang X: Knockdown of ubiquitin protein ligase E3A affects proliferation and invasion, and induces apoptosis of breast cancer cells through regulation of annexin A2. Mol Med Rep. 12:1107–1113. 2015. View Article : Google Scholar : PubMed/NCBI